Caranx Medical has submitted TAVIPILOT Soft, an AI-based guide software for use during Transcatheter Aortic Valve ...

Whether transcatheter aortic-valve replacement can improve outcomes in patients with asymptomatic severe aortic stenosis has been unclear. New research findings comparing TAVR with clinical ...

Anteris Technologies' DurAVR system expected to capture 4%-5% of the U.S. TAVR market by 2030, driven by strong clinician preference for BEV Analyst forecasts DurAVR's superior hemodynamics ...

While the TAVR market is maturing ... our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe.

I am very excited about the real-time guidance of TAVI/TAVR, a key to accurate and precise ... such as TAVI, the Caranx AI-driven software and autonomous robot is at the heart of our mission ...

Edwards Lifesciences' EARLY TAVR trial results highlight significant ... The Company maintains a near-monopoly in the fabrication of nearly every new AI accelerator brought to market over the ...

It's called transcatheter aortic valve replacement — or TAVR. We're learning more with Dr. Clauden Louis, cardiothoracic surgeon with BayCare.

Stifel upgrades Edwards Lifesciences to Buy, citing TAVR growth potential and FDA label expansion in 2025. Edwards' Critical Care sale and focus on structural heart could drive higher valuation ...

Caranx hopes its AI software will make TAVI-TAVR procedures more accessible. Credit: surassawadee via Shutterstock. · Medical Device Network · surassawadee via Shutterstock. Caranx Medical has ...